Complex regulation of telomerase activity: implications for cancer therapy.
作者信息
Elenitoba-Johnson K S
机构信息
Department of Pathology, University of Utah School of Medicine, 50 North Medical Drive, Salt Lake City, UT 84132, USA.
出版信息
Am J Pathol. 2001 Aug;159(2):405-10. doi: 10.1016/S0002-9440(10)61710-5.
Abstract
摘要
相似文献
1
Complex regulation of telomerase activity: implications for cancer therapy.
Am J Pathol. 2001 Aug;159(2):405-10. doi: 10.1016/S0002-9440(10)61710-5.
2
Telomerase: therapeutic potential in cancer.
Cancer Invest. 2000;18(3):269-77. doi: 10.3109/07357900009031830.
3
[Progress on telomere and telomerase].
Wei Sheng Yan Jiu. 2004 May;33(3):369-71.
4
Telomere biology of pediatric cancer.
Cancer Invest. 2007 Apr-May;25(3):197-208. doi: 10.1080/07357900701208683.
5
[Telomere and telomerase associated genes].
Gan To Kagaku Ryoho. 1997 Dec;24(15):2196-201.
6
[Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
Bull Cancer. 1997 Dec;84(12):1123-33.
7
Targeting telomeres and telomerase.
Biochimie. 2008 Jan;90(1):131-55. doi: 10.1016/j.biochi.2007.07.011. Epub 2007 Jul 24.
8
Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Biochimie. 2008 Jan;90(1):156-72. doi: 10.1016/j.biochi.2007.09.002. Epub 2007 Sep 11.
9
Highlights in experimental therapeutics.
Cancer Lett. 2007 Jan 8;245(1-2):11-21. doi: 10.1016/j.canlet.2006.03.012. Epub 2006 May 2.
10
[Advance of research on telomerase].
Gan To Kagaku Ryoho. 1998 Jul;25(8):1105-10.
引用本文的文献
1
An Evaluation of the Stemness, Paracrine, and Tumorigenic Characteristics of Highly Expanded, Minimally Passaged Adipose-Derived Stem Cells.
PLoS One. 2016 Sep 15;11(9):e0162332. doi: 10.1371/journal.pone.0162332. eCollection 2016.
本文引用的文献
1
Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents.
Am J Pathol. 2001 Aug;159(2):711-9. doi: 10.1016/S0002-9440(10)61742-7.
2
Real-time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA: a simple blood test to monitor disease in cancer patients.
Lab Invest. 2001 May;81(5):767-9. doi: 10.1038/labinvest.3780285.
3
Telomerase activation and p53 mutations in urethane-induced A/J mouse lung tumor development.
Carcinogenesis. 2001 May;22(5):751-6. doi: 10.1093/carcin/22.5.751.
4
Reduction of telomerase activity in human liver cancer cells by a histone deacetylase inhibitor.
J Cell Physiol. 2001 Jun;187(3):392-401. doi: 10.1002/jcp.1087.
5
Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase.
Cancer Res. 2001 Apr 1;61(7):3053-61.
6
Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation.
J Immunol. 2001 Apr 15;166(8):4826-30. doi: 10.4049/jimmunol.166.8.4826.
7
Telomerase is regulated by protein kinase C-zeta in human nasopharyngeal cancer cells.
Biochem J. 2001 Apr 15;355(Pt 2):459-64. doi: 10.1042/0264-6021:3550459.
8
Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development.
Int J Cancer. 2001 Mar 1;91(5):644-9.
9
Telomere dysfunction alters the chemotherapeutic profile of transformed cells.
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3381-6. doi: 10.1073/pnas.051629198.
10
Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells.
Cell Growth Differ. 2001 Feb;12(2):119-27.
Zotero 插件